Canada
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
68.17 |
Jan. 14, 2025 | USD 1.93 | -6.31% |
|
Canada |
|
2 |
51.59 |
Jan. 14, 2025 | USD 0.11 | 0.09% |
|
Canada |
|
3 |
30.28 |
Jan. 14, 2025 | USD 7.26 | -2.32% |
|
Canada |
|
4 |
11.37 |
Jan. 14, 2025 | USD 9.40 | -4.39% |
|
Canada |
|
5 |
2.48 |
Jan. 14, 2025 | USD 30.84 | 0.81% |
|
Canada |
|
6 |
1.96 |
Jan. 14, 2025 | USD 23.94 | 0.98% |
|
Canada |
|
7 |
1.64 |
Jan. 14, 2025 | USD 1.53 | -2.45% |
|
Canada |
|
8 |
1.52 |
Jan. 14, 2025 | USD 13.41 | 0.42% |
|
Canada |
|
9 |
1.51 |
Jan. 14, 2025 | USD 2.23 | -6.78% |
|
Canada |
|
10 |
1.50 |
Jan. 14, 2025 | USD 3.69 | 0.40% |
|
Canada |
|
11 |
1.46 |
Jan. 14, 2025 | USD 17.23 | -0.99% |
|
Canada |
|
12 |
1.40 |
Jan. 14, 2025 | USD 1.18 | -0.37% |
|
Canada |
|
13 |
1.36 |
Jan. 14, 2025 | USD 2.70 | 2.33% |
|
Canada |
|
14 |
1.08 |
Jan. 14, 2025 | USD 3.94 | -2.21% |
|
Canada |
|
15 |
0.96 |
Jan. 14, 2025 | USD 1.71 | 4.46% |
|
Canada |
|
16 |
0.83 |
Jan. 14, 2025 | USD 122.81 | -2.58% |
|
Canada |
|
17 |
0.68 |
Jan. 14, 2025 | USD 3.11 | 5.40% |
|
Canada |
|
18 |
0.60 |
Jan. 14, 2025 | USD 4.08 | -3.32% |
|
Canada |
|
19 |
0.34 |
Jan. 14, 2025 | USD 1.51 | -0.70% |
|
Canada |
|
20 |
0.31 |
Jan. 14, 2025 | USD 7.49 | 1.16% |
|
Canada |
The Pharmaceuticals company in Canada with the highest Price to Sales Ratio (P/S) is Lexaria Bioscience Corp. (NasdaqCM: LEXX) at 68.17.
The Pharmaceuticals company in Canada with the lowest Price to Sales Ratio (P/S) is Bausch Health Companies Inc. (Toronto Stock Exchange: BHC.TO) at 0.31.
The top 10 Pharmaceuticals companies in Canada by Price to Sales Ratio (P/S) are Lexaria Bioscience Corp., Ondine Biomedical Inc., Profound Medical Corp., Cipher Pharmaceuticals Inc., Andlauer Healthcare Group Inc., Jamieson Wellness Inc., OrganiGram Holdings Inc., Savaria Corporation, Canopy Growth Corporation and Knight Therapeutics Inc..
The bottom 10 Pharmaceuticals companies in Canada by Price to Sales Ratio (P/S) are Bausch Health Companies Inc., CareRx Corporation, InMed Pharmaceuticals Inc., Medexus Pharmaceuticals Inc., Loblaw Companies Limited, Theratechnologies Inc., Aurora Cannabis Inc., HLS Therapeutics Inc., Tilray Brands, Inc. and Bausch + Lomb Corporation.